Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Capital Reinvestment Ratio
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Capital Reinvestment Ratio of 0.82x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥102.67 Million) in capital expenditures (CN¥83.91 Million). See Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) net asset quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks Xinxiang Tuoxin Pharmaceutical Co.Ltd.'s Capital Reinvestment Ratio across 6 annual periods. Check Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for Xinxiang Tuoxin Pharmaceutical Co.Ltd. from 2019 to 2024. For live market cap and broader valuation context, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.82x | CN¥102.67 Million | CN¥83.91 Million | ▼ -88.1% |
| 2023 | 6.87x | CN¥26.95 Million | CN¥185.22 Million | ▲ +1145.5% |
| 2022 | 0.55x | CN¥268.85 Million | CN¥148.33 Million | ▼ -71.5% |
| 2021 | 1.94x | CN¥58.19 Million | CN¥112.73 Million | ▲ +213.6% |
| 2020 | 0.62x | CN¥120.00 Million | CN¥74.12 Million | ▼ -30.0% |
| 2019 | 0.88x | CN¥86.38 Million | CN¥76.20 Million | — |